Stay on the cutting edge of major market events in drug development. Powered by real-time intelligence, Biomedtracker’s web-based platform tracks and analyzes clinical and regulatory developments so you can quickly and accurately assess a drug's probability of technical success.
How it helps
Biomedtracker's exclusive likelihood of approval analyses highlight the "bottom line" impact of today’s news on your business. Our expert industry analysts draw insights from closely monitoring companies, clinical trials, deals, and regulatory meetings to capture and report on the most critical events.
How it works
Biomedtracker’s intuitive interface features the latest, industry-acclaimed insights, all at your fingertips. We track impactful future catalysts, and then analyze these commercial, clinical, and regulatory activities as they happen, and present them to you via an easily searchable interface that keeps you at the top of your game.
Our analysts attend the medical and investor meetings that matter to you, bringing you not just the news, but vital information on how it impacts your bottom line.
Learn more about the next generation of Biomedtracker